A CRISPR/Cas-Mediated Selection-free Knockin Strategy in Human Embryonic Stem Cells.
about
Site-Specific Genome Engineering in Human Pluripotent Stem CellsBrain tumor modeling using the CRISPR/Cas9 system: state of the art and view to the futureThe Rise of CRISPR/Cas for Genome Editing in Stem CellsEmerging Technologies to Create Inducible and Genetically Defined Porcine Cancer ModelsPatterns of CRISPR/Cas9 activity in plants, animals and microbesAn inducible CRISPR-ON system for controllable gene activation in human pluripotent stem cells.An alternative strategy for targeted gene replacement in plants using a dual-sgRNA/Cas9 design.Minireview: Genome Editing of Human Pluripotent Stem Cells for Modeling Metabolic Disease.Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavageOne-Step Biallelic and Scarless Correction of a β-Thalassemia Mutation in Patient-Specific iPSCs without Drug Selection.A novel Bxb1 integrase RMCE system for high fidelity site-specific integration of mAb expression cassette in CHO Cells.Road to the future of systems biotechnology: CRISPR-Cas-mediated metabolic engineering for recombinant protein production.To CRISPR and beyond: the evolution of genome editing in stem cells.MMEJ-assisted gene knock-in using TALENs and CRISPR-Cas9 with the PITCh systems.CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish.Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells.Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development.CRISPR/Cas-Mediated Knockin in Human Pluripotent Stem Cells.Scarless Genome Editing of Human Pluripotent Stem Cells via Transient Puromycin Selection.A Human IPS Model Implicates Embryonic B-Myeloid Fate Restriction as Developmental Susceptibility to B Acute Lymphoblastic Leukemia-Associated ETV6-RUNX1.Efficient Generation of Somatic Cell Nuclear Transfer-Competent Porcine Cells with Mutated Alleles at Multiple Target Loci by Using CRISPR/Cas9 Combined with Targeted Toxin-Based Selection System.From Reductionism to Holism: Toward a More Complete View of Development Through Genome Engineering.Site-specific randomization of the endogenous genome by a regulatable CRISPR-Cas9 piggyBac system in human cells.Knock-in strategy at 3'-end of Crx gene by CRISPR/Cas9 system shows the gene expression profiles during human photoreceptor differentiation.Transformative therapies for rare CFTR missense alleles.Genome Editing in hPSCs Reveals GATA6 Haploinsufficiency and a Genetic Interaction with GATA4 in Human Pancreatic Development.CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.Efficient In Vivo Liver-Directed Gene Editing Using CRISPR/Cas9.Small molecules promote CRISPR-Cpf1-mediated genome editing in human pluripotent stem cells.The Combinational Use of CRISPR/Cas9 and Targeted Toxin Technology Enables Efficient Isolation of Bi-Allelic Knockout Non-Human Mammalian Clones.Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporation
P2860
Q26747006-2055C1BC-1E8D-4A34-B5AC-BFC84BB44194Q26753206-A7FADEDB-4911-4F5A-B03D-AAF33733505BQ26765852-C16BAB02-31D4-4BDF-BBAE-5BF9C204394AQ26765901-8B6962CF-09D2-42CC-A8AE-CCBC43C6F65AQ28078150-8C4FBBBE-89A6-4BDF-9676-3C9C37E3129EQ30847500-724E9EE7-DE24-43F3-B37A-F54F2DD5D605Q36754951-481C859B-2428-4A63-BF13-64D68F90056FQ36945218-9F95B2E5-E54A-45C8-A8B2-F7B1978F2B86Q37655265-A6E5A806-0B9C-4739-A2D7-0C6414C32AA6Q37718157-433FF00F-A52E-473A-AB9F-8522CBCE0BE6Q38716959-D1FEB9F4-EDD4-4EC5-B3A6-B8C4591A275FQ38774835-28E06F46-B15D-4953-8B68-9551E99E5634Q38788714-4887F328-09CF-4E6B-91A3-0CCBCEBF9F44Q38811005-0E0407D7-2C3A-47AB-AF78-CA27195196F0Q38825322-15637370-C98B-410D-95F3-526121012E70Q39010745-635B3C9B-F849-4D32-9AF6-79E68B12DEFDQ39126523-C586BF70-467E-4E74-8007-86D890C32CD6Q42157982-33FFA37B-A617-4690-AC7F-44BC7B282DECQ47159163-6DD9DF6F-4AE8-4AD7-8AFE-D0BA5942BD6CQ47196011-A1B22F07-4DB7-49B3-88A2-BE93BA811DF8Q47207770-6FBCFAE7-BE8E-450F-9633-E0A2301C807BQ47281756-FA22E8A2-79AE-461E-910E-3A5377221FF0Q47356373-EE0E79C6-779B-467E-8E9D-E2BD30CCD06FQ48267229-8B6FC42D-9C40-46D2-BE9B-8E4957414609Q48857113-128E8E1E-2092-4818-B66D-F6396137F3CDQ50069400-F3484793-D063-4848-A6EF-7948672FEFBEQ50455898-6A54EEF7-2B02-43B1-811E-C90AF4B7E198Q52430638-3071946F-51B4-4F1A-BA88-34AC26AB466BQ52431143-0E6888FA-8953-41BC-B3DC-03E3E4CF141FQ52431255-08B6BAEF-2EF0-4ED0-ABD5-FF75884B87A4Q52431291-34FC8172-0384-4A10-B2C6-02A990A204F4Q58802351-A592AC62-F6B3-4B12-B8BC-59D3E88100A3
P2860
A CRISPR/Cas-Mediated Selection-free Knockin Strategy in Human Embryonic Stem Cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A CRISPR/Cas-Mediated Selection-free Knockin Strategy in Human Embryonic Stem Cells.
@en
type
label
A CRISPR/Cas-Mediated Selection-free Knockin Strategy in Human Embryonic Stem Cells.
@en
prefLabel
A CRISPR/Cas-Mediated Selection-free Knockin Strategy in Human Embryonic Stem Cells.
@en
P2093
P2860
P1433
P1476
A CRISPR/Cas-Mediated Selection-free Knockin Strategy in Human Embryonic Stem Cells.
@en
P2093
Nipun Verma
Zengrong Zhu
Zhong-Dong Shi
P2860
P304
P356
10.1016/J.STEMCR.2015.04.016
P577
2015-05-28T00:00:00Z